NFKB1 and myocarditis: In a SARS-CoV-2 myocarditis model, extracellular vesicles from human umbilical vein endothelial cells inhibit TLR-mediated NFκB activation, reducing myocardial inflammation and mitochondrial damage, and preserving cardiac function [134].